Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4101_Библиотеки_им_академика_М_И_Перельмана
.pdf
151
117. Prabhu S. D., Frangogiannis N. G. The biological basis for cardiac repair after
myocardial infarction: from inflammation to fibrosis. Circulation research, 2016;
119(1), 91-112. doi.org/10.1161/CIRCRESAHA.116.303577
118. Poredos P., Spirkoska A., Lezaic L., Mijovski M. B., Jezovnik M. K. Patients
with an inflamed atherosclerotic plaque have increased levels of circulating
inflammatory markers. Journal of Atherosclerosis and Thrombosis, 2017; 24(1), 39-
46. doi.org/10.5551/jat.34884
119. Quiroga M. M., Miyagishima R., Haendschen L. C., Glovsky M., Martin B. A.,
Hogg J. C. The effect of body temperature on leukocyte kinetics during
cardiopulmonary bypass. The Journal of thoracic and cardiovascular surgery, 1985;
90(1), 91-96. doi.org/10.1016/S0022-5223(19)38668-4
120. Ribatti D. The discovery of the placental growth factor and its role in
angiogenesis: a historical review. Angiogenesis 2008; 11(3):215–21
doi.org/10.1007/s10456-008-9114-4
121. Ridker PM., Bhatt, D.L., Pradhan A.D., Glynn R.J., MacFadyen J.G., Nissen S.E.
Inflammation and cholesterol as predictors of cardiovascular events among patients
receiving statin therapy: a collaborative analysis of three randomised trials. The
Lancet, 2023; 401(10384), 1293-1301. doi.org/10.1016/S0140-6736(23)00215-5
122. Ridker P. M., Thuren T., Zalewski A., Libby P. Interleukin-1β inhibition and the
prevention of recurrent cardiovascular events: rationale and design of the
Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
American heart journal, 2011; 162(4), 597-605. doi.org/10.1016/j.ahj.2011.06.012
123. Ridker P.M., Everett B.M., Thuren T., MacFadyen J.G., Chang W.H., Ballantyne
C. et al. CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for
Atherosclerotic Disease. N Engl J Med. 2017 Sep 21; 377(12):1119-1131. doi:
10.1056/NEJMoa1707914
124. Ridker P. M., Rane M. Interleukin-6 signaling and anti-interleukin-6 therapeutics
in cardiovascular disease. Circulation research, 2021; 128(11), 1728-1746.
doi.org/10.1161/CIRCRESAHA.121.319077
152
125. Rietschel E. T., Westphal O. Endotoxin: historical perspectives. In Endotoxin in
health and disease. 2020; 1-30. CRC Press. doi:10.1201/9781003064961-1
126. Rivas-Fuentes S., Salgado-Aguayo A., Arratia-Quijada J., Gorocica-Rosete P.
Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance
in solid cancer: A mini-review. Journal of Cancer, 2021; 12(2), 571. doi:
10.7150/jca.47022
127. Royse A., Pawanis Z., Canty D., Ou-Young J., Eccleston D., Ajani A. et al. The
effect on survival from the use of a saphenous vein graft during coronary bypass
surgery: a large cohort study. European Journal of Cardio-Thoracic Surgery, 2018;
54(6), 1093-1100. doi.org/10.1093/ejcts/ezy213
128. Saederup N., Xuan W., Liao Y., Chen B., Huang Q., Xu D., et al. Detrimental
effect of fractalkine on myocardial ischaemia and heart failure. Cardiovascular
research, 2011; 92(3), 385-393. doi.org/10.1093/cvr/cvr221
129. Sarzaeem M. R., Mandegar M. H., Roshanali F., Vedadian A., Saidi B., Alaeddini
F. et al. Scoring system for predicting saphenous vein graft patency in coronary artery
bypass grafting. Texas Heart Institute Journal, 2010; 37(5), 525. doi: 10.1016/s0735-
1097(00)00973-6
130. Schulz C., Schafer A., Stolla M. Chemokine fractalkine mediates leukocyte
recruitment to inflammatory endothelial cells in flowing whole blood: a critical role
for P-selectin expressed on activated platelets. Circulation 2007; 116: 764-73.
doi.org/10.1161/CIRCULATIONAHA.107.695189
131. Schulze С., Arellan R., Ganapathy S., Cheng D. Pain and inflammatory response
following off-pump coronary artery bypass grafting. Current Opinion in
Anesthesiology, 2014; 27(1), 106-115. doi: 10.1097/ACO.0000000000000036
132. Schulze C., Conrad N., Schütz A., Eg K., Reichenspurner H., Reichart B. et al.
Reduced expression of systemic proinflammatory cytokines after off-pump versus
conventional coronary artery bypass grafting. The thoracic and cardiovascular
surgeon, 2000; 48(06), 364-369.80. doi 10.3906/прог-1705-131
133. Seraphim A., Knott K. D., Augusto J. B., Menacho K., Tyebally S., Dowsing B.
et al. Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass
153
Graft Surgery: Technical Challenges, Limitations, and Future Directions. Frontiers in
Cardiovascular Medicine. 2021; 8, 795195. doi.org/10.3389/fcvm.2021.795195
134. Sheikhi M.A., Ebadi A., Shahriary A., Davoodzadeh H., Rahmani H. Cardiac
surgery anesthesia and systemic inflammatory response. Int J Bioassays, 2015; 4(2),
3648-3655. doi.org/10.21746/ijbio.2015.02.005
135. Siemens K., Sangaran D.P., Hunt B.J., Murdoch I.A., Tibby S.M. Antifibrinolytic
drugs for the prevention of bleeding in cardiac surgery on cardiopulmonary bypass: a
systematic review and meta-analysis. Anesthesia Analgesia, 2022; 134(5), 987-1001.
doi.org/10.1213/ANE.0000000000005760
136. Skalski B., Kontek B., Rolnik A., Olas B., Stochmal A., Żuchowski J. Anti-
platelet properties of phenolic extracts from the leaves and twigs of Elaeagnus
rhamnoides (L.) A. Nelson. Molecules, 2019; 24(19), 3620.
doi.org/10.3390/molecules24193620\
137. Sproston N. R., Ashworth J. J. Role of C-reactive protein at sites of inflammation
and infection. Frontiers in immunology, 2018; 9, 754.
doi.org/10.3389/fimmu.2018.00754
138. Stephen E. Boag, T lymphocytes and fractalkine contribute to myocardial
ischema reperfusiom injury in patients Volume 125 Number 8 August 2015; P. 3 0 6
3 doi: 10.1172/JCI80055
139. Tabas I., Bornfeldt K. E. Macrophage phenotype and function in different stages
of atherosclerosis. Circulation research, 2016; 118(4), 653-667.
doi.org/10.1161/CIRCRESAHA.115.306256
140. Te Winkel J. P., Drucker N. A., Morocho B. S., Shelley W. C., Markel T. A.
Interleukin-6 therapy improves intestinal recovery following ischemia. Journal of
Surgical Research, 2019; 239, 142-148. doi.org/10.1016/j.jss.2019.02.001
141. Teloh J. K., Ansorge L., Petersen M., Demircioglu E., Waack I. N., Brauckmann
S. Histidine metabolism after Bretschneider cardioplegia in cardiac surgical patients.
Physiological Research, 2018; 67(2). doi.org/10.33549/physiolres.933691
142. Tian M., Wang X., Sun H., Feng W., Song Y., Lu F., Hu S. No-touch versus
conventional vein harvesting techniques at 12 months after coronary artery bypass
154
grafting surgery: multicenter randomized, controlled trial. Circulation. 2021; 144
(14): 1120–9. doi: 10.1161/CIRCULATIONAHA.121.055525
143. Ţintoiu I. C., Bontaş E., Cristian G., Mocanu I., Călinescu F. B., Kibos A. S.
Current Risk Scores for the Establishment of the Best Myocardial Revascularization
Methods. Coronary Graft Failure: State of the Art, 2016 101-129.
doi.org/10.1007/978-3-319-26515-5_10
144. Unüvar S., Tanrıverdi Z., Aslanhan H. Potential prognostic role of immune
system activation marker neopterin in patients with type 2 diabetes. Journal of
Medical Biochemistry, 2018; 37(4), 465. doi: 10.2478/jomb-2018-0004
145. Vandendriessche S., Cambier S., Proost P., Marques P. E. Complement receptors
and their role in leukocyte recruitment and phagocytosis. Frontiers in Cell and
Developmental Biology, 2021; 9, 624025. doi.org/10.3389/fcell.2021.624025
146. Vuong N. L., Elfaituri M. K., Eldoadoa M., Karimzadeh S., Mokhtar M. A., Eid
P. et al. Saphenous vein harvesting techniques for coronary artery bypass grafting: a
systematic review and meta-analysis. Coronary Artery Disease, 2022; 33(2), 128-136.
doi: 10.1097/MCA.0000000000001048
147. Wadey K. Lopes J. Bendeck M. George S. Role of smooth muscle cells in
coronary artery bypass grafting failure. Cardiovasc. Res. 2018; 114 (4): 601–10. doi:
10.1093/cvr/cvy021
148. Wang Y., Shi X., Du R., Chen Y. Zhang Q. Off-pump versus on-pump coronary
artery bypass grafting in patients with diabetes: a meta-analysis. Acta diabetologica,
2017; 54, 283-292. doi.org/10.1007/s00592-016-0951-0
149. Watanabe, T. Neopterin derivatives–a novel therapeutic target rather than
biomarker for atherosclerosis and related diseases. Vasa, 2021; №2
doi.org/10.1024/0301-1526/a000903
150. Weglarz P., Bochenek T., Bajor G., Mizia-Stec K., Krejca M. Early stage of
atherosclerosis in aortocoronary saphenous vein grafts: intravascular ultrasound
study. J. Cardiovasc. Surg. 2019; 34: 560–4. doi: 10.21470/1678-9741-2018-0221
151. Yang P., Tan J., Yuan Z., Meng G., Bi L., Liu J. Expression profile of cytokines
and chemokines in osteoarthritis patients: Proinflammatory roles for CXCL8 and
155
CXCL11 to chondrocytes. International immunopharmacology, 2016; 40, 16-23.
doi.org/10.1016/j.intimp.2016.08.005
152. Yasuda K.; Nakanishi K.; Tsutsui H. Interleukin-18 in Health and Disease. Int. J.
Mol. Sci. 2019; 20, 649. doi.org/10.3390/ijms20030649
153. Zhang H.; Park Y.; Wu J.; Chen X.; Lee S.; Yang J. et al. Role of TNF-alpha in
vascular dysfunction. Clin. Sci. 2009; 116, 219–230. doi.org/10.1042/CS20080196
154. Zhu M., Lei L., Zhu Z., Li Q., Guo D., Xu J. et al. Excess TNF-alpha in the blood
activates monocytes with the potential to directly form cholesteryl ester-laden cells.
Acta Biochim. Biophys. Sin. 2015; 47, 899–907. doi.org/10.1093/abbs/gmv092
155. Zouridakis E., Avanzas P., Arroyo-Espliguero R., Fredericks S., Kaski J. C.
Markers of inflammation and rapid coronary artery disease progression in patients
with stable angina pectoris. Circulation, 2004; 110(13), 1747-1753.
doi.org/10.1161/01.CIR.0000142664.18739.92
Соседние файлы в папке Библиотека им академика М.И. Перельмана